<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>7428490</pmcid><all-ids><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmid">32558376</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmc">7428490</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="doi">10.1002/brb3.1725</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="publisher-id">BRB31725</article-id></all-ids><extracted-table><table-id>brb31725-tbl-0001</table-id><table-label>TABLE 1</table-label><table-caption>Demographic, clinical, and cognitive data in the T2DM and HC groups</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="brb31725-tbl-0001" xml:lang="en" content-type="TABLE" orientation="portrait" position="float"><label>TABLE 1</label><caption><p>Demographic, clinical, and cognitive data in the T2DM and HC groups</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Items</th><th align="left" valign="top" rowspan="1" colspan="1">T2DM group (<italic>n</italic> = 38)</th><th align="left" valign="top" rowspan="1" colspan="1">HC group (<italic>n</italic> = 33)</th><th align="left" valign="top" rowspan="1" colspan="1"><italic>p</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="left" rowspan="1" colspan="1">55.71 ± 6.32</td><td align="left" rowspan="1" colspan="1">54.01 ± 4.99</td><td align="left" rowspan="1" colspan="1">.231</td></tr><tr><td align="left" rowspan="1" colspan="1">Gender (M/F)</td><td align="left" rowspan="1" colspan="1">30/8</td><td align="left" rowspan="1" colspan="1">26/7</td><td align="left" rowspan="1" colspan="1">.987</td></tr><tr><td align="left" rowspan="1" colspan="1">Education (years)</td><td align="left" rowspan="1" colspan="1">13.29 ± 2.50</td><td align="left" rowspan="1" colspan="1">15.18 ± 1.88</td><td align="left" rowspan="1" colspan="1">.001<xref ref-type="fn" rid="brb31725-note-0005">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Disease duration (years)</td><td align="left" rowspan="1" colspan="1">8.13 ± 5.88</td><td align="left" rowspan="1" colspan="1">–</td><td align="left" rowspan="1" colspan="1">–</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td align="left" rowspan="1" colspan="1">24.59 ± 2.81</td><td align="left" rowspan="1" colspan="1">24.61 ± 3.10</td><td align="left" rowspan="1" colspan="1">.970</td></tr><tr><td align="left" rowspan="1" colspan="1">Systolic BP (mmHg)</td><td align="left" rowspan="1" colspan="1">126.21 ± 12.82</td><td align="left" rowspan="1" colspan="1">123.24 ± 8.66</td><td align="left" rowspan="1" colspan="1">.264</td></tr><tr><td align="left" rowspan="1" colspan="1">Diastolic BP (mmHg)</td><td align="left" rowspan="1" colspan="1">79.63 ± 9.84</td><td align="left" rowspan="1" colspan="1">82.18 ± 6.10</td><td align="left" rowspan="1" colspan="1">.202</td></tr><tr><td align="left" rowspan="1" colspan="1">HbA1c (%)</td><td align="left" rowspan="1" colspan="1">8.10 ± 1.86</td><td align="left" rowspan="1" colspan="1">5.67 ± 0.54</td><td align="left" rowspan="1" colspan="1">&lt;.001<xref ref-type="fn" rid="brb31725-note-0005">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">FBG (mmol/L)</td><td align="left" rowspan="1" colspan="1">9.16 ± 2.90</td><td align="left" rowspan="1" colspan="1">5.37 ± 0.87</td><td align="left" rowspan="1" colspan="1">&lt;.001<xref ref-type="fn" rid="brb31725-note-0005">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">TG (mmol/L)</td><td align="left" rowspan="1" colspan="1">2.18 ± 1.28</td><td align="left" rowspan="1" colspan="1">1.74 ± 1.17</td><td align="left" rowspan="1" colspan="1">.495</td></tr><tr><td align="left" rowspan="1" colspan="1">TC (mmol/L)</td><td align="left" rowspan="1" colspan="1">4.67 ± 1.53</td><td align="left" rowspan="1" colspan="1">4.93 ± 0.92</td><td align="left" rowspan="1" colspan="1">.396</td></tr><tr><td align="left" rowspan="1" colspan="1">MMSE</td><td align="left" rowspan="1" colspan="1">28.00 ± 2.01</td><td align="left" rowspan="1" colspan="1">28.46 ± 1.60</td><td align="left" rowspan="1" colspan="1">.301</td></tr><tr><td align="left" rowspan="1" colspan="1">MoCA</td><td align="left" rowspan="1" colspan="1">26.50 ± 2.67</td><td align="left" rowspan="1" colspan="1">27.02 ± 1.48</td><td align="left" rowspan="1" colspan="1">.311</td></tr><tr><td align="left" rowspan="1" colspan="1">TMT‐A</td><td align="left" rowspan="1" colspan="1">74.50 ± 27.04</td><td align="left" rowspan="1" colspan="1">71.58 ± 26.51</td><td align="left" rowspan="1" colspan="1">.866</td></tr><tr><td align="left" rowspan="1" colspan="1">CDT</td><td align="left" rowspan="1" colspan="1">17.88 ± 6.94</td><td align="left" rowspan="1" colspan="1">19.36 ± 5.70</td><td align="left" rowspan="1" colspan="1">.333</td></tr><tr><td align="left" colspan="4" rowspan="1">T2DM complications</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Retinopathy</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">–</td><td align="left" rowspan="1" colspan="1">–</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Peripheral neuropathy</td><td align="left" rowspan="1" colspan="1">21</td><td align="left" rowspan="1" colspan="1">–</td><td align="left" rowspan="1" colspan="1">–</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Nephropathy</td><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">–</td><td align="left" rowspan="1" colspan="1">–</td></tr><tr><td align="left" colspan="4" rowspan="1">T2DM therapeutic agents</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Dietary restriction</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">–</td><td align="left" rowspan="1" colspan="1">–</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Oral medication</td><td align="left" rowspan="1" colspan="1">18</td><td align="left" rowspan="1" colspan="1">–</td><td align="left" rowspan="1" colspan="1">–</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Insulin</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">–</td><td align="left" rowspan="1" colspan="1">–</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Insulin + oral medication</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">–</td><td align="left" rowspan="1" colspan="1">–</td></tr></tbody></table><table-wrap-foot id="brb31725-ntgp-0002"><fn id="brb31725-note-0004"><p>Abbreviations: BMI, body mass index; CDT, Clock Drawing Test; FBG, fasting blood glucose; HbA1c, glycated hemoglobin; MMSE, Mini‐Mental State Examination; MoCA, Montreal Cognitive Assessment; TC, total cholesterol; TG, triglycerides; TMT‐A, trail making test A.</p></fn><fn id="brb31725-note-0005"><label>*</label><p><italic>p </italic>&lt; .05.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder></permissions></table-wrap></original-table><transformed-table>TABLE 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Demographic, clinical, and cognitive data in the T2DM and HC groups</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000"/><col style="border-right:solid 1px #000000"/><col style="border-right:solid 1px #000000"/><col style="border-right:solid 1px #000000"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top">Items</th><th align="left" valign="top">T2DM group (n = 38)</th><th align="left" valign="top">HC group (n = 33)</th><th align="left" valign="top">p</th></tr></thead><tbody><tr><td align="left">Age (years)</td><td align="left">55.71 ± 6.32</td><td align="left">54.01 ± 4.99</td><td align="left">.231</td></tr><tr><td align="left">Gender (M/F)</td><td align="left">30/8</td><td align="left">26/7</td><td align="left">.987</td></tr><tr><td align="left">Education (years)</td><td align="left">13.29 ± 2.50</td><td align="left">15.18 ± 1.88</td><td align="left">.001???</td></tr><tr><td align="left">Disease duration (years)</td><td align="left">8.13 ± 5.88</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left">BMI (kg/m2)</td><td align="left">24.59 ± 2.81</td><td align="left">24.61 ± 3.10</td><td align="left">.970</td></tr><tr><td align="left">Systolic BP (mmHg)</td><td align="left">126.21 ± 12.82</td><td align="left">123.24 ± 8.66</td><td align="left">.264</td></tr><tr><td align="left">Diastolic BP (mmHg)</td><td align="left">79.63 ± 9.84</td><td align="left">82.18 ± 6.10</td><td align="left">.202</td></tr><tr><td align="left">HbA1c (%)</td><td align="left">8.10 ± 1.86</td><td align="left">5.67 ± 0.54</td><td align="left">&lt;.001???</td></tr><tr><td align="left">FBG (mmol/L)</td><td align="left">9.16 ± 2.90</td><td align="left">5.37 ± 0.87</td><td align="left">&lt;.001???</td></tr><tr><td align="left">TG (mmol/L)</td><td align="left">2.18 ± 1.28</td><td align="left">1.74 ± 1.17</td><td align="left">.495</td></tr><tr><td align="left">TC (mmol/L)</td><td align="left">4.67 ± 1.53</td><td align="left">4.93 ± 0.92</td><td align="left">.396</td></tr><tr><td align="left">MMSE</td><td align="left">28.00 ± 2.01</td><td align="left">28.46 ± 1.60</td><td align="left">.301</td></tr><tr><td align="left">MoCA</td><td align="left">26.50 ± 2.67</td><td align="left">27.02 ± 1.48</td><td align="left">.311</td></tr><tr><td align="left">TMT‐A</td><td align="left">74.50 ± 27.04</td><td align="left">71.58 ± 26.51</td><td align="left">.866</td></tr><tr><td align="left">CDT</td><td align="left">17.88 ± 6.94</td><td align="left">19.36 ± 5.70</td><td align="left">.333</td></tr><tr><td align="left" colspan="4">T2DM complications</td></tr><tr><td align="left" style="padding-left:10%">Retinopathy</td><td align="left">8</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left" style="padding-left:10%">Peripheral neuropathy</td><td align="left">21</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left" style="padding-left:10%">Nephropathy</td><td align="left">22</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left" colspan="4">T2DM therapeutic agents</td></tr><tr><td align="left" style="padding-left:10%">Dietary restriction</td><td align="left">12</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left" style="padding-left:10%">Oral medication</td><td align="left">18</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left" style="padding-left:10%">Insulin</td><td align="left">2</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left" style="padding-left:10%">Insulin + oral medication</td><td align="left">6</td><td align="left">–</td><td align="left">–</td></tr></tbody></table></div>Abbreviations: BMI, body mass index; CDT, Clock Drawing Test; FBG, fasting blood glucose; HbA1c, glycated hemoglobin; MMSE, Mini‐Mental State Examination; MoCA, Montreal Cognitive Assessment; TC, total cholesterol; TG, triglycerides; TMT‐A, trail making test A.*p &lt; .05.John Wiley &amp; Sons, Ltd</transformed-table></extracted-table><extracted-table><table-id>brb31725-tbl-0002</table-id><table-label>TABLE 2</table-label><table-caption>Aberrant functional connectivity in the T2DM group compared with the HC group</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="brb31725-tbl-0002" xml:lang="en" content-type="TABLE" orientation="portrait" position="float"><label>TABLE 2</label><caption><p>Aberrant functional connectivity in the T2DM group compared with the HC group</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="2" valign="bottom" colspan="1">Seed ROI</th><th align="left" rowspan="2" valign="bottom" colspan="1">Brain regions</th><th align="left" colspan="3" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Peak MNI coordinates</th><th align="left" rowspan="2" valign="bottom" colspan="1">Voxels</th><th align="left" rowspan="2" valign="bottom" colspan="1">BA</th><th align="left" rowspan="2" valign="bottom" colspan="1">Peak t score</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">X</th><th align="left" valign="bottom" rowspan="1" colspan="1">Y</th><th align="left" valign="bottom" rowspan="1" colspan="1">Z</th></tr></thead><tbody><tr><td align="left" rowspan="7" colspan="1">Right posterior cerebellum</td><td align="left" rowspan="1" colspan="1">R middle/inferior occipital gyrus</td><td align="char" char="." rowspan="1" colspan="1">36</td><td align="char" char="." rowspan="1" colspan="1">−93</td><td align="char" char="." rowspan="1" colspan="1">−6</td><td align="char" char="." rowspan="1" colspan="1">57</td><td align="left" rowspan="1" colspan="1">18/19</td><td align="left" rowspan="1" colspan="1">−4.55</td></tr><tr><td align="left" rowspan="1" colspan="1">L middle temporal gyrus</td><td align="char" char="." rowspan="1" colspan="1">−57</td><td align="char" char="." rowspan="1" colspan="1">−24</td><td align="char" char="." rowspan="1" colspan="1">−6</td><td align="char" char="." rowspan="1" colspan="1">82</td><td align="left" rowspan="1" colspan="1">21/22</td><td align="left" rowspan="1" colspan="1">−4.99</td></tr><tr><td align="left" rowspan="1" colspan="1">L superior frontal gyrus</td><td align="char" char="." rowspan="1" colspan="1">−15</td><td align="char" char="." rowspan="1" colspan="1">69</td><td align="char" char="." rowspan="1" colspan="1">3</td><td align="char" char="." rowspan="1" colspan="1">46</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">−4.84</td></tr><tr><td align="left" rowspan="1" colspan="1">L insula</td><td align="char" char="." rowspan="1" colspan="1">−39</td><td align="char" char="." rowspan="1" colspan="1">−21</td><td align="char" char="." rowspan="1" colspan="1">18</td><td align="char" char="." rowspan="1" colspan="1">44</td><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">−5.04</td></tr><tr><td align="left" rowspan="1" colspan="1">L middle frontal gyrus</td><td align="char" char="." rowspan="1" colspan="1">−24</td><td align="char" char="." rowspan="1" colspan="1">51</td><td align="char" char="." rowspan="1" colspan="1">27</td><td align="char" char="." rowspan="1" colspan="1">43</td><td align="left" rowspan="1" colspan="1">9/10</td><td align="left" rowspan="1" colspan="1">−5.34</td></tr><tr><td align="left" rowspan="1" colspan="1">L precuneus</td><td align="char" char="." rowspan="1" colspan="1">−6</td><td align="char" char="." rowspan="1" colspan="1">−66</td><td align="char" char="." rowspan="1" colspan="1">51</td><td align="char" char="." rowspan="1" colspan="1">33</td><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">−4.94</td></tr><tr><td align="left" rowspan="1" colspan="1">R paracentral lobule/L precuneus</td><td align="char" char="." rowspan="1" colspan="1">−9</td><td align="char" char="." rowspan="1" colspan="1">−42</td><td align="char" char="." rowspan="1" colspan="1">69</td><td align="char" char="." rowspan="1" colspan="1">33</td><td align="left" rowspan="1" colspan="1">4/5</td><td align="left" rowspan="1" colspan="1">−4.33</td></tr><tr><td align="left" rowspan="2" colspan="1">Right insula</td><td align="left" rowspan="1" colspan="1">L medial frontal gyrus</td><td align="char" char="." rowspan="1" colspan="1">0</td><td align="char" char="." rowspan="1" colspan="1">51</td><td align="char" char="." rowspan="1" colspan="1">24</td><td align="char" char="." rowspan="1" colspan="1">49</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">−4.20</td></tr><tr><td align="left" rowspan="1" colspan="1">L supplementary motor area</td><td align="char" char="." rowspan="1" colspan="1">−12</td><td align="char" char="." rowspan="1" colspan="1">15</td><td align="char" char="." rowspan="1" colspan="1">66</td><td align="char" char="." rowspan="1" colspan="1">38</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">−5.98</td></tr><tr><td align="left" rowspan="1" colspan="1">Left lingual gyrus</td><td align="left" rowspan="1" colspan="1">R middle/inferior occipital gyrus</td><td align="char" char="." rowspan="1" colspan="1">42</td><td align="char" char="." rowspan="1" colspan="1">−87</td><td align="char" char="." rowspan="1" colspan="1">3</td><td align="char" char="." rowspan="1" colspan="1">71</td><td align="left" rowspan="1" colspan="1">18/19</td><td align="left" rowspan="1" colspan="1">−4.83</td></tr></tbody></table><permissions><copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder></permissions></table-wrap></original-table><transformed-table>TABLE 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Aberrant functional connectivity in the T2DM group compared with the HC group</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000"/><col style="border-right:solid 1px #000000"/><col style="border-right:solid 1px #000000"/><col style="border-right:solid 1px #000000"/><col style="border-right:solid 1px #000000"/><col style="border-right:solid 1px #000000"/><col style="border-right:solid 1px #000000"/><col style="border-right:solid 1px #000000"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="2" valign="bottom">Seed ROI</th><th align="left" rowspan="2" valign="bottom">Brain regions</th><th align="left" colspan="3" style="border-bottom:solid 1px #000000" valign="bottom">Peak MNI coordinates</th><th align="left" rowspan="2" valign="bottom">Voxels</th><th align="left" rowspan="2" valign="bottom">BA</th><th align="left" rowspan="2" valign="bottom">Peak t score</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom">X</th><th align="left" valign="bottom">Y</th><th align="left" valign="bottom">Z</th></tr></thead><tbody><tr><td align="left" rowspan="7">Right posterior cerebellum</td><td align="left">R middle/inferior occipital gyrus</td><td align="char" char=".">36</td><td align="char" char=".">−93</td><td align="char" char=".">−6</td><td align="char" char=".">57</td><td align="left">18/19</td><td align="left">−4.55</td></tr><tr><td align="left">L middle temporal gyrus</td><td align="char" char=".">−57</td><td align="char" char=".">−24</td><td align="char" char=".">−6</td><td align="char" char=".">82</td><td align="left">21/22</td><td align="left">−4.99</td></tr><tr><td align="left">L superior frontal gyrus</td><td align="char" char=".">−15</td><td align="char" char=".">69</td><td align="char" char=".">3</td><td align="char" char=".">46</td><td align="left">10</td><td align="left">−4.84</td></tr><tr><td align="left">L insula</td><td align="char" char=".">−39</td><td align="char" char=".">−21</td><td align="char" char=".">18</td><td align="char" char=".">44</td><td align="left">13</td><td align="left">−5.04</td></tr><tr><td align="left">L middle frontal gyrus</td><td align="char" char=".">−24</td><td align="char" char=".">51</td><td align="char" char=".">27</td><td align="char" char=".">43</td><td align="left">9/10</td><td align="left">−5.34</td></tr><tr><td align="left">L precuneus</td><td align="char" char=".">−6</td><td align="char" char=".">−66</td><td align="char" char=".">51</td><td align="char" char=".">33</td><td align="left">7</td><td align="left">−4.94</td></tr><tr><td align="left">R paracentral lobule/L precuneus</td><td align="char" char=".">−9</td><td align="char" char=".">−42</td><td align="char" char=".">69</td><td align="char" char=".">33</td><td align="left">4/5</td><td align="left">−4.33</td></tr><tr><td align="left" rowspan="2">Right insula</td><td align="left">L medial frontal gyrus</td><td align="char" char=".">0</td><td align="char" char=".">51</td><td align="char" char=".">24</td><td align="char" char=".">49</td><td align="left">9</td><td align="left">−4.20</td></tr><tr><td align="left">L supplementary motor area</td><td align="char" char=".">−12</td><td align="char" char=".">15</td><td align="char" char=".">66</td><td align="char" char=".">38</td><td align="left">6</td><td align="left">−5.98</td></tr><tr><td align="left">Left lingual gyrus</td><td align="left">R middle/inferior occipital gyrus</td><td align="char" char=".">42</td><td align="char" char=".">−87</td><td align="char" char=".">3</td><td align="char" char=".">71</td><td align="left">18/19</td><td align="left">−4.83</td></tr></tbody></table></div>John Wiley &amp; Sons, Ltd</transformed-table></extracted-table></extracted-tables-set>